# Docetaxel

NDC: 70121-1222
Generic name: Docetaxel
Labeler / Manufacturer: Amneal Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20180119

FDA application: ANDA209640

## Active ingredients

- DOCETAXEL ANHYDROUS: 80 mg/4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70121-1222"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70121-1222
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=67508df6-b96f-46fa-a792-0afcdfa9810e